Published in Cancer Weekly, December 1st, 2009
Patients received 50, 65, 85, 110 and 132mg/m2 doses in a cohort...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.